As summarized in Figure 1, several inflammation-linked analytes (e.g., CRP, ESR, LDH) exhibited distributions that are directionally consistent with known pathophysiology, while other markers displayed disease-specific density shifts that help differentiate between entities such as COVID-19, asthma, pneumonia, and other complications. The gene discussed is ESR1; the disease is asthma.